ARK Genomic Revolution ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, ARK Genomic Revolution ETF (ARKG) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 3.6%, relative volume 1.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | TEM | 9.42% | $116M |
| 2 | TWST | 8.99% | $111M |
| 3 | CRSP | 8.91% | $110M |
| 4 | TXG | 5.77% | $71M |
| 5 | BEAM | 5.43% | $67M |
| 6 | ABSI | 4.78% | $59M |
| 7 | NTRA | 4.07% | $50M |
| 8 | ILMN | 4.03% | $50M |
| 9 | NTLA | 3.82% | $47M |
| 10 | PSNL | 3.58% | $44M |
| 11 | RXRX | 3.51% | $43M |
| 12 | GH | 3.49% | $43M |
| 13 | CDNA | 3.38% | $42M |
| 14 | VCYT | 2.66% | $33M |
| 15 | CMPS | 2.43% | $30M |
| 16 | ADPT | 2.42% | $30M |
| 17 | NRIX | 2.33% | $29M |
| 18 | WGS | 2.04% | $25M |
| 19 | SDGR | 2.03% | $25M |
| 20 | ARCT | 1.96% | $24M |
| 21 | BFLY | 1.89% | $23M |
| 22 | IONS | 1.74% | $22M |
| 23 | ATAI | 1.48% | $18M |
| 24 | PRME | 1.41% | $17M |
| 25 | PACB | 1.41% | $17M |
Showing 25 of 32 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARKG Jan avg: 6.27% median: 9.52% win: 75% σ: 14.34% n: 4 2022-04-12 → 2026-07-31 | ARKG Feb avg: -2.22% median: -4.88% win: 25% σ: 9.42% n: 4 2022-04-12 → 2026-07-31 | ARKG Mar avg: -9.30% median: -10.30% win: 0% σ: 6.27% n: 4 2022-04-12 → 2026-07-31 | ARKG Apr avg: -4.81% median: -3.69% win: 40% σ: 14.82% n: 5 2022-04-12 → 2026-07-31 | ARKG May avg: 4.08% median: 5.20% win: 60% σ: 9.13% n: 5 2022-04-12 → 2026-07-31 | ARKG Jun avg: 7.81% median: 7.78% win: 60% σ: 11.25% n: 5 2022-04-12 → 2026-07-31 | ARKG Jul avg: 6.40% median: 11.47% win: 60% σ: 10.99% n: 5 2022-04-12 → 2026-07-31 | ARKG Aug avg: -4.12% median: -2.57% win: 25% σ: 7.94% n: 4 2022-04-12 → 2026-07-31 (current) | ARKG Sep avg: -2.91% median: -5.19% win: 25% σ: 11.06% n: 4 2022-04-12 → 2026-07-31 | ARKG Oct avg: -3.04% median: -3.45% win: 50% σ: 13.05% n: 4 2022-04-12 → 2026-07-31 | ARKG Nov avg: 7.31% median: 6.23% win: 75% σ: 11.13% n: 4 2022-04-12 → 2026-07-31 | ARKG Dec avg: -2.84% median: -8.24% win: 25% σ: 14.29% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 32 tickers across 32 holdings rows (99.6% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| ALMRALAMAR BIOSCIENCES INC | — → 1.21% | — |
| BNTXBIONTECH SE | — → 1.06% | — |
| LLYELI LILLY & COMPANY | — → 0.95% | — |
| GENBGENERATE BIOMEDICINES INC | — → 0.51% | — |
| Holding | Before → after | Δ weight |
|---|---|---|
| ABSIABSCI CORP | 2.82% → 4.78% | +1.96 pp |
| TWSTTWIST BIOSCIENCE CORP | 7.19% → 8.99% |
Holdings of ARKG currently on TickerStance stock-RS leaderboards.
| +1.80 pp |
| CMPSCOMPASS PATHWAYS PLC | 1.13% → 2.43% | +1.30 pp |
| TEMTEMPUS AI INC | 8.25% → 9.42% | +1.17 pp |
| CRSPCRISPR THERAPEUTICS AG | 7.99% → 8.91% | +0.92 pp |
+8 more
| Holding | Before → after | Δ weight |
|---|---|---|
| PSNLPERSONALIS INC | 6.13% → 3.58% | −2.55 pp |
| GHGUARDANT HEALTH INC | 5.98% → 3.49% | −2.49 pp |
| IONSIONIS PHARMACEUTICALS INC | 2.61% → 1.74% | −0.87 pp |
| ADPTADAPTIVE BIOTECHNOLOGIES CORP | 3.12% → 2.42% | −0.70 pp |
| VCYTVERACYTE INC | 3.28% → 2.66% | −0.62 pp |
+9 more
| Holding | Before → after | Δ weight |
|---|---|---|
| AMGNAmgen Inc | 1.21% → — | — |
| INCYIncyte Corp | 1.07% → — | — |
| VRTXVertex Pharmaceuticals Inc | 0.96% → — | — |
| CAICaris Life Sciences Inc | 0.74% → — | — |
| VEEVVeeva Systems Inc | 0.66% → — | — |
+1 more
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| 2.33% |
| 1Y RS |
| 178 |
| Stage 2 |